Amble Tirzepatide 99% Purity GLP-1 Agonist for Research Use

Amble Tirzepatide is a novel dual GIP/GLP-1 receptor agonist currently under investigation for type 2 diabetes and obesity treatment applications. This synthetic peptide demonstrates superior metabolic effects compared to single-receptor agonists.

The compound features a molecular structure based on the glucose-dependent insulinotropic polypeptide amino acid sequence, modified with a C20 fatty diacid moiety to extend its half-life to approximately 5 days, enabling once-weekly subcutaneous administration in clinical settings.

Research indicates Amble Tirzepatide produces dose-dependent reductions in glycated hemoglobin levels and body weight. The dual agonist mechanism appears to improve tolerability while allowing more aggressive dosing regimens compared to single-receptor agonists.

Key Research Applications:

1. Investigational weight loss agent
2. Type 2 diabetes management studies
3. Metabolic syndrome research
4. Appetite regulation mechanisms
5. Glucose homeostasis investigations

The product is supplied as white lyophilized powder in vials, with options for custom packaging and bulk quantities available for research institutions and pharmaceutical developers.

Storage and Handling:

For optimal stability, store Amble Tirzepatide at 2-8°C protected from light and moisture. Avoid repeated freeze-thaw cycles. Reconstituted solutions should be used immediately or stored at -20°C for short-term use.

This product is intended for research purposes only. Not for human consumption.